Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) – Market Forecast, 2025–2034

The global placenta market size is expected to reach USD 1,404.87 million by 2034, according to a new study by Polaris Market Research. The report “Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Placental tissues and extracts are utilized in reproductive medicine to enhance uterine health, improve embryo implantation rates, and support overall fertility. Couples undergoing assisted reproductive technologies (ART), such as in-vitro fertilization (IVF), are increasingly turning to placenta-based treatments to enhance their chances of conception. Clinical research suggests that bioactive compounds found in placental extracts improve endometrial receptivity, making embryo implantation more successful. As infertility rates continue to rise due to factors such as lifestyle changes, stress, and delayed pregnancies, the need for innovative solutions such as placenta-derived fertility treatments is expected to grow. Thus, the expanding use of the placenta in fertility treatments is contributing to placenta market growth.

The rising awareness of placenta applications in dermatology, trichology, and reproductive medicine continues to fuel demand. With alopecia areata becoming more prevalent, particularly among women and certain ethnic groups, the need for advanced treatments utilizing the placenta’s regenerative properties is growing. Ongoing scientific research is enhancing the effectiveness of placenta-based products, broadening their use across medical and cosmetic fields.

The placenta market is expanding rapidly as demand for placenta-derived products grows across the medical and cosmetic industries. From antiaging skincare to hair care and fertility treatments, the use of placental extracts is driving innovation and investment. The increasing preference for natural and scientifically backed solutions is fueling the placenta market demand. Companies are continuously developing new formulations, driving the market expansion. Ongoing advancements keep the market a significant player in the beauty, health, and wellness industries.

Placenta Market Report Highlights

Based on type, the porcine segment dominated the placenta market share in 2024 due to its versatility and availability of porcine placenta. Porcine (pig) placenta is emerging as a valuable resource in the market, owing to its rich composition of collagen, proteins, and bioactive peptides.

The pharmaceuticals segment, by application, is estimated to register the highest CAGR during the forecast period. In the pharmaceutical segment, placental extracts have been explored for their therapeutic properties. The rich composition of bioactive molecules such as growth factors, cytokines, and extracellular vesicles makes placental extracts promising candidates for therapeutic applications.

North America dominated the global placenta market revenue share in 2024 due to factors such as increasing demand for placenta-based cosmetics, health supplements, and pharmaceutical products.

The market in Asia Pacific is expected to register the highest CAGR in the coming years owing to rising prevalence of rare diseases such as muscular dystrophy and growing demand for placenta-based supplements.

A few global key market players are Japan Natural Laboratories Co., Ltd.; Japan Bio Products Co., Ltd.; Albert David Limited; Atlanta Placenta Encapsulation; MIMEDX Group, Inc.; PURTIER Placenta; The Placenta Company; Smith and Nephew; Mommy Made Encapsulation; and Nubloom LLC.

Polaris Market Research has segmented the placenta market report on the basis of type, application, and region:

By Type Outlook (Revenue, USD Million, 2020–2034)

Porcine

Equine

Ovine

Others

By Application Outlook (Revenue, USD Million, 2020–2034)

Pharmaceuticals

Cosmetics

Supplements

Others

By Regional Outlook (Revenue, USD Million, 2020–2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Russia

Italy

Spain

Netherlands

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

Israel

UAE

Rest of Middle East & Africa

Latin America

Brazil

Mexico

Argentina

Rest of Latin America Show more